Universal Ibogaine (TSXV:IBO) Days Sales Outstanding : 36.17 (As of Jan. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Universal Ibogaine Days Sales Outstanding?

Universal Ibogaine's average Accounts Receivable for the three months ended in Jan. 2024 was C$0.23 Mil. Universal Ibogaine's Revenue for the three months ended in Jan. 2024 was C$0.59 Mil. Hence, Universal Ibogaine's Days Sales Outstanding for the three months ended in Jan. 2024 was 36.17.

The historical rank and industry rank for Universal Ibogaine's Days Sales Outstanding or its related term are showing as below:

TSXV:IBO' s Days Sales Outstanding Range Over the Past 10 Years
Min: 0 Med: 0 Max: 38.34
Current: 38.34

During the past 7 years, Universal Ibogaine's highest Days Sales Outstanding was 38.34. The lowest was 0.00. And the median was 0.00.

TSXV:IBO's Days Sales Outstanding is ranked better than
78.54% of 890 companies
in the Biotechnology industry
Industry Median: 72.665 vs TSXV:IBO: 38.34

Universal Ibogaine's Days Sales Outstanding increased from Jan. 2023 (0.00) to Jan. 2024 (36.17).

Universal Ibogaine Days Sales Outstanding Historical Data

The historical data trend for Universal Ibogaine's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Ibogaine Days Sales Outstanding Chart

Universal Ibogaine Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Jul22

Jul23

Days Sales Outstanding

Get a 7-Day Free Trial

Universal Ibogaine Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Days Sales Outstanding	Get a 7-Day Free Trial															-	-	-	34.75	36.17

Competitive Comparison of Universal Ibogaine's Days Sales Outstanding

For the Biotechnology subindustry, Universal Ibogaine's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Universal Ibogaine's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Universal Ibogaine's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Universal Ibogaine's Days Sales Outstanding falls into.

Universal Ibogaine Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Universal Ibogaine's Days Sales Outstanding for the fiscal year that ended in Jul. 2023 is calculated as

	Days Sales Outstanding (A: Jul. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jul. 2022 )	+	Accounts Receivable (A: Jul. 2023 ))	/	count )	/	Revenue (A: Jul. 2023 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	1.03	*	365
=	0					/	1.03	*	365
=	0.00

Universal Ibogaine's Days Sales Outstanding for the quarter that ended in Jan. 2024 is calculated as:

	Days Sales Outstanding (Q: Jan. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Oct. 2023 )	+	Accounts Receivable (A: Jan. 2024 ))	/	count )	/	Revenue (A: Jan. 2024 )	*	Days in Period
=	( (0.246	+	0.221)	/	2 )	/	0.589	*	365 / 4
=	0.2335					/	0.589	*	365 / 4
=	36.17

Universal Ibogaine (TSXV:IBO) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Universal Ibogaine Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Universal Ibogaine's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Universal Ibogaine (TSXV:IBO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Universal Ibogaine Inc (TSXV:IBO) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

IBOGF:USA JC4:Germany

Address

400 3rd Avenue South west, Suite 1470, Calgary, AB, CAN, T2P 4H2

Website

https://www.universalibogaine.com

Universal Ibogaine Inc develops a platform of addiction treatment clinics, which use ibogaine as a primary modality for the interruption and ideally cessation of addictions to primarily opioids such as oxycodone, heroin, fentanyl, as well as alcohol, cocaine, and other stimulants. It runs addiction clinics it has a research partner clinic in Mexico.

Universal Ibogaine (TSXV:IBO) Headlines

No Headlines